Questions and answers on the 2019 ESC Guidelines


Know your ESCGuidelines?

According to the 2019 ESC/EAS Dyslipidaemia Guidelines, the addition of a PCSK9 inhibitor is recommended for patients already taking a maximally tolerated statin dose and ezetimibe if the LDL-C goal is not achieved:

 

Answer : Correct answer is D.